Komori
Pharma Foods International (2929) · InitiativeRestated

Managing profitability through changes to the measurement method for segment profit

First written in FY2019-Q1. 2 of 3 entries say "Restated". Latest entry: FY2019-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2019-Q32018: 120182019: 22019
Same theme, other companies
Change in the Method of Measuring Reporting Segment ProfitA theme 118 companies write about · 0 as a headwind · 19 as a tailwind

72 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 118 companies compared. The sentences above are computed from all 118.
Full recordFilings, disclosures and news, newest first
  1. FY2019-Q3RestatedAnnual report

    「From the first quarter of the fiscal year, the Company has changed from allocating corporate expenses and goodwill amortization to each reportable segment to disclosing the profit or loss of each segment itself and presenting corporate expenses and goodwill amortization as adjustments.」

    The Company continues to use a measurement method that clarifies the profit or loss of each segment itself and presents corporate expenses and other items as adjustments.
  2. FY2019-Q2RestatedAnnual report

    「From the first quarter of the fiscal year, the Company has changed from allocating corporate expenses and goodwill amortization to each reportable segment to disclosing the profit or loss of each reportable segment itself and presenting corporate expenses and goodwill amortization as adjustments.」

    The Company continues to use a measurement method that clarifies the profit or loss of each segment itself and presents corporate expenses and other items as adjustments.
  3. FY2019-Q1First statedAnnual report

    「From the consolidated first quarter, the company changed from allocating corporate expenses and amortization of goodwill to each reportable segment to disclosing the profit or loss of each reportable segment itself and presenting corporate expenses and amortization of goodwill as adjustments. The purpose is to clarify the profit or loss of each reportable segment in line with its actual operations while managing these costs efficiently to improve profitability.」

    The company changed its presentation method by separating corporate expenses and amortization of goodwill from each segment and presenting them as adjustments, clarifying the profit or loss of the segments themselves. The stated objectives are efficient management and improved profitability.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.